In silico de novo drug design of a therapeutic peptide inhibitor against UBE2C in breast cancer.
Andrea Mae AñonuevoMarineil C. GomezLemmuel Lara TayoPublished in: J. Bioinform. Comput. Biol. (2023)
Keyphrases
- drug design
- breast cancer
- tandem mass spectra
- breast cancer patients
- mass spectrometry
- drug discovery
- cancer patients
- tandem mass spectrometry
- mass spectra
- protein structure prediction
- protein protein interactions
- biological data
- protein sequences
- high throughput
- diagnosis of breast cancer
- logistic regression
- systems biology
- amino acids
- ms ms
- gene regulatory networks
- mammogram images
- clinical trials
- biological networks
- microarray
- decision trees
- machine learning
- biological systems
- clinical data
- early stage